Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...
Mayor Zohran Mamdani’s drive to expand “free” (city-run, taxpayer-funded) preschool programs is already squeezing private-sector providers, suggesting this “transformation” is more about a government ...
In 2021, Arizona softball had nine run-rule victories in 10 games. The one that kept them from going 10 straight was an extra-inning affair against Oregon State. That kept the program record for ...
Luke Lindberg, USDA's undersecretary for trade and foreign agricultural affairs. (USDA photo) Luke Lindberg, USDA’s undersecretary for trade and foreign agricultural affairs, is the leading contender ...
CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...
When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...
Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...
If a user opened this Markdown file in Windows 11 Notepad versions 11.2510 and earlier and viewed it in Markdown mode, the above text would appear as a clickable link. If the link is clicked with ...
TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...
Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.